Synapse Microcurrent Ltd. is a leading medical technology based company specializing in developing and taking to market clinically proven medical devices to promote advanced tissue healing in a variety of different applications.
Incorporated in January 2003, Synapse focussed its efforts in the early years in refining and securing the rights to patented technology in tissue viability. Evidence of this came in 2007 when Synapse was awarded ISO 9001:2000* accreditation for the design and manufacture of its micro-current devices for medical, veterinary and sports applications.

Commenting on this achievement John Gildersleeve, Chief Executive of Synapse Micro-current Ltd said, "Synapse are committed to providing quality products and services. This is demonstrated by the very high level of repeat business from our customers, who recognise the important connection between quality and value. Achieving ISO 9001:2000 certification for our established quality management system, shows our commitment to providing the high quality and traceability that our customers expect."

In addition, Synapse gained the ISO 13485:2003 accreditation. David Chapman-Jones, Director of Medicine and Science said "We are delighted to achieve ISO 13485:2003 accreditation for our Accel Heal and Tendonworks units. Synapse aims to comply with the highest possible standards in the medical devices industry and this quality management system will ensure a basis for continuously meeting regulatory requirements now and in the future. This achievement demonstrates our absolute commitment to the quality of our medical devices and meeting customers expectations."

*ISO 9001 is the internationally recognised standard for Quality Management Systems (QMS). ISO 13485 is based on the ISO 9001:2000 process model approach and is a management systems standard specifically developed for the manufacture of medical devices which is audited continuously by a certified notified body. Its primary objective is to facilitate harmonised medical device regulatory requirements.

How does the Synapse micro-current unit differ from other electrical treatment devices?
In simple terms it is the level or strength of the current used that differentiates one electrical treatment device from another. Synapse micro-current operates at similar levels to the body’s natural electrical systems. In general terms micro-current uses a very low level of current, operating at cellular level.
This is in contrast to devices using stronger intensity that can cause muscle contractions as a cause of mechanical effect.
In our body cellular activity and intercellular communication is regulated (chemically) by electricity and it is the efficiency of this communication process which is key to a normal physiological state.The supposition behind Synapse micro-current treatments is that damaged or disrupted (electro-chemical) pathways (caused by illness, injury and extreme conditions such as intense exercise) can be reignited.

Synapse’s patented programs are specifically based on the understanding that different cell types respond to different treatment parameters. Cellular activity is sensitive to the treatment and laboratory studies have demonstrated that cells can be turned 'off' as well as 'on'. Therefore, if treatment parameters are not accurately delivered there is the potential to have a detrimental effect. If programs are not within specific parameters we would question the efficacy.

We would claim our patented programs are quite specific and proven - the result of nearly 15 years research.
The programs are specific - ie the tendonworks unit is different to the recovery unit. We know and have proved that cells behave very differently, they are also very sensitive to the treatment - we have been able to turn cells 'off' as well as 'on' so if the treatment parameters are not accurately delivered they can have a detrimental effect - the same goes for the treatment time.
We accept we are not at the optimum by any means but we know to be most effective it needs to be within our parameters.
If programs are not within these parameters we would question the efficacy.
Same goes for the accuracy of the electronics and design - Our units are accurate to 0.001 % Again less accuracy = less efficacy.
Finally in addition to your acknowledged ease of use our units have a patented solution to the very 'real world' problem of skin resistance.
We have carried out a large amount of research into skin resistance. Healthy skin, different ethnicity, different conditions all give varying problems to delivering precise current to the area below the skin surface. Our units indicate when they are not delivering the programs accurately or effectively. Once notified, remedial action can be taken such as skin preperation, until the treatment can be delivered. To illustrate - you could attach a competitors electrode to a piece of wood/ metal/ car and it would indicate it was delivering it's alleged program. in short you're completely in the dark as to what it's doing.

Currently the clinical applications and related products are:-
Wound Care - facilitating an accelerated rate of healing in all wounds focusing upon chronic and difficult to heal wounds.
Tendon Healing - the augmentation of the production of type 1 collagen to promote the regenerative sequence of normal tendon cyclical tissue turnover.
"Sport" Recovery - Post exercise lactic acid/related fatigue reduction.
"Sport" Performance - Increases the levels of Adenosine Tri-Phosphate (ATP). AMP-activated protein kinase (AMPK)

An independent phase III trial (Chronic Wounds) has recently been completed which succesfully demonstrated Synapse Accel-Heal™ efficacy with Chronic non healing wounds

The Sports division continues to flourish with the continued use by many elite athletes & teams. The Recovery & Performance micro-current units both contain the latest versions of Synapse's proven sports technology in devices, smaller, lighter and cheaper than previously available.